Combined insulin-like growth factor-1 and growth hormone improves weight loss and wound healing in burned rats

被引:38
作者
Meyer, NA
Barrow, RE
Herndon, DN
机构
[1] SHRINERS BURN INST, GALVESTON, TX 77550 USA
[2] UNIV TEXAS, MED BRANCH, GALVESTON, TX 77550 USA
来源
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE | 1996年 / 41卷 / 06期
关键词
D O I
10.1097/00005373-199612000-00011
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The anabolic effects of growth hormone (GH) in burned patients appear to act both directly and through insulin-like growth factor-1 (IGF-1). We, therefore, hypothesize that exogenous GH plus IGF-1 will attenuate increases in metabolism and lean muscle wasting while promoting wound healing. Materials and Methods: Rats, each weighing 440-470g, were given a 35% total body surface area, full-thickness scald burn and divided into four groups to receive placebo (burned controls), bovine GH (2.5 mg/kg/day), IGF-1 (2.0 mg/kg/day), or bovine GH plus rhIGF-1 (2.5 + 2.0 mg/kg/day), respectively, for 8 weeks. Results: Total body weight gain after 8 weeks averaged 110g for GH plus IGF-1 compared with gains of 49 and 11g for GH or IGF-1 alone, respectively. Burned controls lost 24g, Metabolic rates were significantly reduced in all groups receiving growth hormones. Gastroenemius muscle dry weight was significantly increased in those receiving GH plus IGF-1 compared with GH and IGF-1 alone or burned controls (p < .01). Conclusions: Data show that GH plus IGF-1 synergistically increased lean muscle height, total/body weight, and was more effective in re-epithelialization of the burn wound than either GH or IGF-1 alone.
引用
收藏
页码:1008 / 1012
页数:5
相关论文
共 50 条
[31]  
MANSON JM, 1986, SURGERY, V100, P188
[32]   REGULATION OF INSULIN-LIKE GROWTH FACTOR-I GENE-EXPRESSION BY GROWTH-HORMONE [J].
MATHEWS, LS ;
NORSTEDT, G ;
PALMITER, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (24) :9343-9347
[33]   CHARACTERIZATION OF INSULIN-LIKE GROWTH FACTOR-I/SOMATOMEDIN-C RECEPTORS ON HUMAN KERATINOCYTE MONOLAYERS [J].
MISRA, P ;
NICKOLOFF, BJ ;
MORHENN, VB ;
HINTZ, RL ;
ROSENFELD, RG .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1986, 87 (02) :264-267
[34]   GROWTH-HORMONE REGULATION OF SERUM-LIPOPROTEINS IN THE RAT - DIFFERENT GROWTH-HORMONE REGULATORY PRINCIPLES FOR APOLIPOPROTEIN (APO)-B AND THE SEXUALLY DIMORPHIC APO-E CONCENTRATIONS [J].
OSCARSSON, J ;
OLOFSSON, SO ;
VIKMAN, K ;
EDEN, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (11) :1191-1198
[35]  
PELL JM, 1987, J ENDOCRINOL A, V68, P68
[36]   COMPARISON OF SOMATOMEDIN ACTIVITY IN PERFUSATES OF NORMAL AND HYPOPHYSECTOMIZED RAT LIVERS WITH AND WITHOUT ADDED GROWTH-HORMONE [J].
PHILLIPS, LS ;
HERINGTON, AC ;
KARL, IE ;
DAUGHADAY, WH .
ENDOCRINOLOGY, 1976, 98 (03) :606-614
[37]  
PONTING GA, 1988, LANCET, V1, P438, DOI 10.1016/S0140-6736(88)91232-9
[38]   MULTIPLICATION STIMULATING ACTIVITY (MSA) FROM THE BRL 3A RAT-LIVER CELL-LINE - RELATION TO HUMAN SOMATOMEDINS AND INSULIN [J].
RECHLER, MM ;
NISSLEY, SP ;
KING, GL ;
MOSES, AC ;
VANOBBERGHENSCHILLING, EE ;
ROMANUS, JA ;
KNIGHT, AB ;
SHORT, PA ;
WHITE, RM .
JOURNAL OF SUPRAMOLECULAR STRUCTURE AND CELLULAR BIOCHEMISTRY, 1981, 15 (03) :253-286
[39]  
SHERMAN SK, 1989, SURG FORUM, V166, P739
[40]  
SHERNAN S K, 1989, Surgical Forum (Chicago), V40, P37